Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88.
Monoclonal antibody MAB-T88 is a human monoclonal immunoglobulin M antibody directed at the lipopolysaccharide of gram-negative bacteria. In this study, nine patients who were expected to become neutropenic from antineoplastic chemotherapy received an infusion of MAB-T88, three patients at each of t...
Saved in:
| Published in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology (ASM)
1992
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245503/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1444318/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.10.2349 |
| Tags: |
No Tags, Be the first to tag this record!
|